Defining Personalized Medicine in Melanoma and Cutaneous Malignancies

Sanjiv S. Agarwala, MD

Video Categories: Personalized Medicine

Listen as Dr Agarwala describes the nuances of personalized medicine as they relate to melanoma and cutaneous malignancies.
June 16, 2015

The Biomarker: Melanoma

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.

March 31, 2015

New Targets = Better Standard of Care

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.